MetaCap

Harrow Statistics

NASDAQ: HROWHealth CareBiotechnology: Pharmaceutical PreparationsUSD

30.41-1.72 (-5.35%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Harrow by the numbers

Harrow has a market capitalization of $1.14 billion based on 37.53M shares outstanding. With trailing EPS of $-0.76, Harrow is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.9% above its 50-day average and 18.1% below its 200-day average.

Average daily trading volume is 626.20K shares, or about $19.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

HROW valuation vs. peer median

HROW compared with the median of 8 peer companies
MetricHROWPeer medianDifference
Market cap$1.14B$1.16B-2%
Avg. volume626.20K901.39K-31%

Peer median across 8 companies: CMPS, GPCR, AAPG, OPK, KARD, GHRS, AMPH, MLYS.

Valuation

Price / sales (latest FY)
4.19
EPS (TTM)
$-0.76

Price and trading

Previous close
32.13
Open
31.95
Day range
30.32 – 32.43
52-week range
25.76 – 54.85
52-week change
-21.85%
Beta
—
Volume
911.03K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.14B
Forward Pe
16.26
Eps
-0.76
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
54.85
Week52 Low
25.76
Avg Volume
626.20K
Shares Outstanding
37.53M
Ma50
30.14
Ma200
37.14
Earnings Date
Nov 9, 2026
Pct From52w High
-44.56%
Pct From52w Low
18.05%

Related